Naturally acquired antibodies to Plasmodium vivax blood-stage vaccine candidates (PvMSP-1 19 and PvMSP-3α 359-798) and their relationship with hematological features in malaria patients from the Brazilian Amazon

Microbes and Infection

Volumn 14, Issue 9, 2012, Pages 730-739

  Mourão, Luiza Carvalho ^a   Morais, Cristiane Guimarães ^a   Bueno, Lilian Lacerda ^a   Jimenez, Maria Carolina ^b   Soares, Irene Silva ^b   Fontes, Cor Jesus ^c   Guimarães Lacerda, Marcus Vinícius ^d   Xavier, Marcos Silva ^a   Barnwell, John W ^e   Galinski, Mary R ^f   Braga, Érika Martins ^a  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

^c FEDERAL UNIVERSITY OF MATO GROSSO   (Brazil)

^d Fundacao de Medicina Tropical Dr Heitor Vieira Dourado   (Brazil)

^e CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^f EMORY UNIVERSITY   (United States)

Author keywords

Antibodies; Malaria vaccine; Merozoite antigens; Plasmodium vivax

Indexed keywords

ANTIBODY; HEMOGLOBIN; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2; IMMUNOGLOBULIN G3; MALARIA VACCINE; MEROZOITE SURFACE PROTEIN 1; MEROZOITE SURFACE PROTEIN 119; MEROZOITE SURFACE PROTEIN 3ALPHA359 798; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGE; AGED; ANEMIA; ANTIBODY RESPONSE; ARTICLE; BRAZIL; CHILD; CORRELATION ANALYSIS; HUMAN; HUMORAL IMMUNITY; IMMUNOGENICITY; MAJOR CLINICAL STUDY; MORBIDITY; PARASITEMIA; PATHOGENESIS; PLASMODIUM VIVAX; PLASMODIUM VIVAX MALARIA; PRIORITY JOURNAL; SCHOOL CHILD; SCORING SYSTEM; THROMBOCYTOPENIA;

ADOLESCENT; ADULT; AGED; ANTIBODIES, PROTOZOAN; ANTIGENS, PROTOZOAN; BRAZIL; CHILD; FEMALE; HUMANS; IMMUNOGLOBULIN G; MALARIA VACCINES; MALARIA, VIVAX; MALE; MEROZOITE SURFACE PROTEIN 1; MIDDLE AGED; PLASMODIUM VIVAX; PROTOZOAN PROTEINS; YOUNG ADULT;

PLASMODIUM VIVAX;

EID: 84863106551     PISSN: 12864579     EISSN: 1769714X     Source Type: Journal    
DOI: 10.1016/j.micinf.2012.02.011     Document Type: Article

References (50)

1. Guerra C.A., Howes R.E., Patil A.P., Gething P.W., Van Boeckel T.P., Temperley W.H., Kabaria C.W., Tatem A.J., Manh B.H., Elyazar I.R.F., Baird J.K., Snow R.W., Hay S.I. The international limits and population at risk of Plasmodium vivax transmission in 2009. PLoS Negl. Trop. Dis. 2010, 4:e774.
2. Oliveira-Ferreira J., Lacerda M.V.G., Brasil P., Ladislau J.L.B., Tauil P.L., Daniel-Ribeiro C.T. Malaria in Brazil: an overview. Malar. J. 2010, 9:115.
3. Alexandre M.A., Ferreira C.O., Siqueira A.M., Magalhães B.L., Magalhães M.P.G., Lacerda M.V., Alecrim M.G.C. Severe Plasmodium vivax malaria, Brazilian Amazon. Emerg. Infect. Dis. 2010, 16:1611-1614.
4. Genton B., DAcremonte V., Rare L., Baea K., Reeder J.C., Alpers M.P., Muller I. Plasmodium vivax and mixed infections are associated with severe malaria in children: a prospective cohort study from Papua New Guinea. PLoS Med. 2008, 5:e127.
5. Anstey N.M., Russell B., Yeo T.W., Price R.N. The pathophysiology of vivax malaria. Trends Parasitol. 2009, 25:220-227.
6. Richards J.S., Beeson J.G. The future for blood-stage vaccines against malaria. Immunol. Cell Biol. 2009, 87:377-390.
7. Blackman M.J., Heidrich H., Donachie S., McBride J.S., Holder A.A. A single fragment of a malaria merozoite surface protein remains on the parasite during red cell invasion and is the target of invasion-inhibiting antibodies. J. Exp. Med. 1990, 172:379-382.
8. Holder A.A., Blackman M.J., Burghaus P.A., Chappel J.A., Ling I.T., McCallum-Deighton N., Shai S. A malaria merozoite surface protein (MSP1)-structure, processing and function. Mem. Inst. Oswaldo Cruz. 1992, 87:37-42.
9. Branch O.H., Udhayakumar V., Hightower A.W., Oloo A.J., Hawley W.A., Nahlen B.L., Bloland P.B., Kaslow D.C., Lal A.A. A longitudinal investigation of IgG and IgM antibody responses to the merozoite surface protein-1 19-kiloDalton domain of Plasmodium falciparum in pregnant women and infants: associations with febrile illness, parasitemia, and anemia. Am. J. Trop. Med. Hyg 1998, 58:211-219.
10. Egan A.F., Burghaus P., Druilhe P., Holder A.A., Riley E.M. Human antibodies to the 19 kDa C-terminal fragment of Plasmodium falciparum merozoite surface protein 1 inhibit parasite growth in vitro. Parasite Immunol. 1999, 21:133-139.
11. McColl D.J., Silva A., Foley M., Kun J.F.J., Favaloro J.M., Thompson J.K., Marshall V.M., Coppel R.L., Kemp D.J., Anders R.F. Molecular variation in a novel polymorphic antigen associated with Plasmodium falciparum merozoites. Mol. Biochem. Parasitol. 1994, 68:53-67.
12. Galinski M.R., Corredor-Medina C., Povoa M., Crosby J., Ingravallo P., Barnwell J.W. Plasmodium vivax merozoite surface protein-3 contains coiled-coil motifs in an alanine-rich central domain. Mol. Biochem. Parasitol. 1999, 101:131-147.
13. Oevray C., Bouharoun-Tayoun H., Gras-Masse H., Bottius E., Kaidoh T., Aikawa M., Filgueira M., Tartar A., Druilhe P. Merozoite surface protein-3: a malaria protein inducing antibodies that promote Plasmodium falciparum killing by cooperation with blood monocytes. Blood 1994, 84:1594-1602.
14. Roussilhon C., Oevray C., Muller-Graaf C., Tall A., Rogier C., Trape J., Theisen M., Balde A., Pérignon J., Druilhe P. Long-term clinical protection from falciparum malaria is strongly associated with IgG3 antibodies to merozoite surface protein 3. PLoS Med. 2007, 4:e320.
15. Sirima B., Cousins S., Druilhe P. Protection against malaria by MSP3 candidate vaccine. N. Engl. J. Med. 2011, 365:1062-1064.
16. Galinski M.R., Ingravallo P., Corredor-Medina C., Al-Khedery B., Povoa M., Barnwell J.W. Plasmodium vivax merozoite surface proteins-3 beta and-3 gamma share structural similarities with P. vivax merozoite surface protein-3alpha and define a new gene family. Mol. Biochem. Parasitol. 2001, 115:41-53.
17. Singh S., Soe S., Weisman S., Barnwell J.W., Pérignon J.L., Druilhe P. A conserved multi-gene family induces cross-reactive antibodies effective in defense against Plasmodium falciparum. PLoS One 2009, 4:e5410.
18. Scopel K.K.G., Fontes C.J.F., Nunes A.C., Horta M.F., Braga E.M. Low sensitivity of nested PCR using Plasmodium DNA extracted from stained thick blood smears: an epidemiological retrospective study among subjects with low parasitemias in a Brazilian Amazon endemic area. Malar. J. 2004, 3:e8.
19. Soares I.S., Barnwell J.W., Ferreira M.U., Cunha M.G., Laurino J.P., Castilho B.A., Rodrigues M.M. A Plasmodium vivax vaccine candidate displays limited allele polymorphism, which does not restrict recognition by antibodies. Mol. Med. 1999, 5:459-470.
20. Barnwell J.M., Galinski M.R., Simone S.G., Perler F., Ingravallo P. Plasmodium vivax, P. cynomolgi, P. knowlesi: identification of homologue proteins associated with the surface of merozoites. Exp. Parasitol. 1999, 91:238-249.
21. 19 expressed in distinct bacterial vectors. Vaccine 2001, 20:385-396.
22. Jimenez M.C.S., Ramos C.H.I., Barbosa A.R.G., Galinski M.R., Barnwell J.W., Rodrigues M.M., Soares I.S. Biophysical characterization of the recombinant merozoite surface protein-3 of Plasmodium vivax. Biochim. Biophys. Acta 2008, 1780:983-988.
23. Braga E.M., Barros R.M., Reis T.A., Fontes C.J.F., Morais C.G., Martins M.S., Krettli A.U. Association of the IgG response to Plasmodium falciparum merozoite protein (C-terminal 19 kD) with clinical immunity to malaria in the Brazilian Amazon region. Am. J. Trop. Med. Hyg. 2002, 66:461-466.
24. Morais C.G., Soares I.S., Carvalho L.H., Fontes C.J.F., Krettli A.U., Braga E.M. IgG isotype to C-terminal 19kDa of Plasmodium vivax merozoite surface protein 1 among subjects with different levels of exposure to malaria in Brazil. Parasitol. Res. 2005, 95:420-426.
25. Abdi H., Williams L.J. Principal component analysis. Wiley Interdiscip. Rev. Comp. Stat. 2010, 2:433-459.
26. Jollife I.T. Principal Component Analysis 2002, Springer, New York, NY. second ed..
27. Kaiser H.F. The application of electronic computers to factor analysis. Educ. Psychol. Meas. 1960, 20:141-151.
28. Guadagnoli E., Velicer W.F. Relation of sample size to the stability of component patterns. Psychol. Bull. 1988, 103:265-275.
29. Quintero J.P., Siqueira A.M., Tobón A., Blair S., Moreno A., Arévalo-Herrera M., Lacerda M.V.G., Valencia S.H. Malaria-related anemia: a Latin America perspective. Mem. Inst. Oswaldo Cruz 2011, 106:91-104.
30. Wickramasingle S.N., Abdalla S.H. Blood and bone marrow changes in malaria. Baillieres Clin. Haematol. 2000, 13:277-299.
31. Barbedo M.B., Ricci R., Jimenez M.C.S., Cunha M.G., Yazdani S.S., Chitnis C.E., Rodrigues M.M., Soares I.S. Comparative recognition by human IgG antibodies of recombinant proteins representing three asexual erythrocytic stage vaccine candidates of Plasmodium vivax. Mem. Inst. Oswaldo Cruz 2007, 102:335-339.
32. 19 across distantly related Plasmodium species. Nat. Med. 2000, 6:91-95.
33. Putaporntip C., Jongwutiwes S., Sakihama N., Ferreira M.U., Kho W., Kaneko A., Kanbara H., Hattori T., Tanabe K. Mosaic organization and heterogeneity in frequency of allelic recombination of the Plasmodium vivax merozoite surface protein-1 locus. Proc. Natl. Acad. Sci. U S A 2002, 99:16348-16353.
34. Gowda D.C. TLR-mediated cell signaling by malaria GPIs. Trends Parasitol. 2007, 23:596-604.
35. Carlton J.M., Adams J.H., Silva J.C., Bidwell S.L., lorenzi H., Caler E., Crabtree J., Angiuoli S.V., Merino E.F., Amedeo P., Cheng Q., Coulson R.M., Crabb B.S., Del Portillo H.A., Essien K., Feldblyum T.V., Fernandez-Becerra C., Gilson P.R., Gueye A.H., Guo X., Kang'a S., Kooij T.W., Korsinczky M., Meyer E.V., Nene V., Paulsen I., White O., Ralph S.A., Ren Q., Sargeant T.J., Salzberg S.L., Stoeckert C.J., Sullivan S.A., Yamamoto M.M., Hoffman S.L., Wortman J.R., Gardner M.J., Galinski M.R., Barnwell J.W., Fraser-Liggett C.M. Comparative genome of the neglected human malaria parasite Plasmodium vivax. Nature 2008, 455:757-763.
36. Prajapati S.K., Joshi H., Valecha N. Plasmodium vivax merozoite surface protein-3α: a high-resolution marker for genetic diversity studies. J. Vector Borne Dis. 2010, 47:85-90.
37. Rayner J.C., Corredor V., Feldman D., ingravallo P., Iderabdullah F., Galinski M.R., Barnwell J.W. Extensive polymorphism in the Plasmodium vivax merozoite surface coat protein MSP-3α is limited to specific domains. Parasitology 2002, 125:393-405.
38. Fernandez-Becerra C., Sanz S., Brucet M., Stanisic D.I., Alves F.P., Camargo E.P., Alonso P.L., Mueller I., Del Portillo A. Naturally-acquired humoral immune responses against the N- and C-termini of the Plasmodium vivax MSP1 protein in endemic regions of Brazil and Papua New Guinea using a multiplex assay. Malar. J. 2010, 9:29.
39. Zeyrek F.Y., Babaoglu A., Demirel S., erdogan D.D., Ak M., Korkmaz M., Coban C. Short report: analysis of naturally acquired antibody responses to the 19-kd C-terminal region of merozoite surface protein-1 of Plasmodium vivax from individuals in Sanliurfa, Turkey. Am. J. Trop. Med. Hyg. 2008, 78:729-732.
40. Lima-Júnior J.C., Jiang J., Rodrigues-da-Silva R.N., Banic D.M., Tran T.M., Ribeiro R.Y., Meyer V.S.E., De-Simone S.G., Santos F., Moreno A., Barnwell J.W., Galinski M.R., Oliveira-Ferreira J. B cell epitope mapping and characterization of naturally acquired antibodies to the Plasmodium vivax merozoite surface protein-3α (PvMSP-3α) in malaria exposed individuals from Brazilian Amazon. Vaccine 2011, 29:1801-1811.
41. Chang K., Stevenson M.M. Malarial anaemia: mechanisms and implications of insufficient erythropoiesis during blood-stage malaria. Int. J. Parasitol. 2004, 34:1501-1516.
42. Ghosh K., Gosh K. Pathogenesis of anemia in malaria: a concise review. Parasitol. Res. 2007, 101:1463-1469.
43. Jaoko W.G., Michel E., Meyrowitsch D.W., Estambale B.B.A., Malecela M.N., Simonsen P.E. Immunoepidemiology of Wuchereria bancrofti infection: parasite transmission intensity, filaria-specific antibodies, and host immunity in two East African communities. Infect. Immun. 2007, 75:5651-5662.
44. Mutapi F., Winborn G., Midzi N., Taylor M., Mduluza T., Maizels R.M. Cytokine responses to Schistosoma haematobium in a Zimbabwean population: contrasting profiles for INF-γ, IL-4, IL-5 and IL-10 with age. BMC Infect. Dis. 2007, 7:139.
45. Wilson S., Jones F.M., Mwatha J.K., Kimani G., Booth M., Kariuki H.C., Vennervald B.J., Ouma J.H., Muchiri E., Dunne D.W. Hepatosplenomegaly is associated with low regulatory and Th2 responses to Schistosome antigen in childhood schistosomiasis and malaria coinfection. Infect. Immun. 2008, 76:2212-2218.
46. Awah N.W., Troye-Blomberg M., Berzins K., Gysin J. Mechanisms of malarial anemia: potential involvement of the Plasmodium falciparum low molecular weight rhoptry-associated proteins. Acta Trop. 2009, 112:295-302.
47. Awah N., Balogun H., Achidi E., Mariuba L.A., Nogueira P.A., Orlandi P., Troye-Blomberg M., Gysin J., Berzins K. Antibodies to the Plasmodium falciparum rhoptry protein RAP-2/RSP-2 in relation to anaemia in Cameroonian children. Parasite Immunol. 2011, 33:104-115.
48. Sterkers Y., Scheidig C., Rocha M., Lepolard C., Gysin j., Scherf A. Members of the low-molecular-mass rhoptry protein complex of Plasmodium falcipaum bind to the surface of normal erythrocytes. J. Infect. Dis. 2007, 196:617-621.
49. Mibei E.K., Orago A.S.S., Stoute J.A. Immune complex levels in children with severe Plasmodium falciparum malaria. Am. J. Trop. Med. Hyg. 2005, 72:593-599.
50. Facer C.A. Direct Coombs antiglobulin reaction in gambian children with Plasmodium falciparum malaria. Clin. Exp. Immunol. 1980, 39:279-288.